# SOGROYA

NDC: 0169-2035
Generic name: somapacitan-beco
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230501

FDA application: BLA761156

## Active ingredients

- SOMAPACITAN: 3.3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2035"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2035
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eadd03b4-adc3-4b88-8a24-9d205c5b85aa